For sale is an established medical-grade hyperbaric oxygen therapy provider serving an affluent Colorado market with limited direct competition. Operating for nearly two decades, the company has developed a strong referral network and maintains valuable contracts with Medicare, Aetna, Anthem Blue Cross Blue Shield, Cigna, and United Healthcare, creating a significant barrier to entry and supporting favorable reimbursement rates.

Highlights:
-Valuable contracts with Medicare and major commercial insurance carriers
-Strong referral relationships with hospitals, wound care providers, and specialists
-Average revenue per treatment of approximately $480–$500
-Insurance patients represent approximately 20% of patient volume but generate more than 70% of revenue
-Highly recurring revenue driven by multi-session treatment protocols
-Virtually no paid advertising, creating significant growth opportunities
-Expansion potential through additional Colorado locations
-Affiliated regenerative medicine clinic also available for acquisition

Revenue declined temporarily in 2024 due to disruptions within the local referral network following changes at two regional wound care programs. Given the high revenue generated by individual insurance patients, a small reduction in referrals had a noticeable impact on annual results. The seller believes the decline was temporary and not reflective of the company’s underlying performance.

The transaction is expected to be structured as a stock sale, allowing a buyer to retain the company’s existing EIN, NPI enrollment, and highly valuable insurance contracts. No medical license or prior hyperbaric experience is required, provided qualified clinical staff and physician oversight remain in place.

**Sign the NDA here: https://businessexits.com/listing/medical_grade_hbot_insurance/